Logo image of BCAX

BICARA THERAPEUTICS INC (BCAX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:BCAX - US0554771032 - Common Stock

16.53 USD
-0.19 (-1.14%)
Last: 1/21/2026, 12:51:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
BCAX revenue by date.BCAX revenue by date.
N/AN/AN/AN/AN/A
805.80%		N/A
266.27%		N/A
63.44%		N/A
49.83%		N/A
29.19%
EBITDA
YoY % growth
BCAX ebitda by date.BCAX ebitda by date.
-37.646M-39.87M
-5.91%		-82.333M
-106.50%		N/A
-86.46%		N/A
-23.33%		N/A
-10.98%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
BCAX ebit by date.BCAX ebit by date.
-37.656M-39.889M
-5.93%		-82.389M
-106.55%		N/A
-92.59%		N/A
4.06%		N/A
-38.89%		N/A
-11.11%		N/A
8.97%		N/A
116.62%		N/A
540.96%		N/A
154.68%		N/A
34.35%
Operating Margin
BCAX operating margin by date.BCAX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
BCAX eps by date.BCAX eps by date.
N/AN/AN/AN/A
3.44%		N/A
-21.13%		N/A
2.29%		N/A
20.94%		N/A
-8.37%		N/A
47.38%		N/A
75.00%		N/A
589.55%		N/A
12.20%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.69
-76.91%		-0.71
-4.33%		-0.74
-48.17%		-0.80
-19.66%		-0.85
-22.75%		-0.54
23.23%		-0.56
24.83%		-0.57
29.01%		-0.58
31.35%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		-42.025M
-58.10%		-43.177M
-3.37%		-44.134M
-38.01%		-47.421M
-16.76%		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-42.945M
-61.22%		-43.554M
-4.23%		-45.234M
-41.28%		-48.261M
-18.65%		-51.623M
-20.21%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -0.67
58.13%		-0.56-0.11-19.60%
Q2 2025
Q2Q % growth		 -0.50 -0.580.0813.77%
Q1 2025
Q2Q % growth		 -0.68 -0.42-0.26-60.69%
Q4 2024
Q2Q % growth		 -0.39 -0.33-0.06-18.22%
Q3 2024
Q2Q % growth		 -1.60 -0.47-1.13-241.01%
BCAX Yearly EPS VS EstimatesBCAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 -2 -3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
BCAX Yearly Revenue VS EstimatesBCAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.64% -17.13% 0% -9.67%
RevenueN/A N/A N/A N/A